Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010984
Filing Date
2025-05-15
Accepted
2025-05-15 16:30:58
Documents
74
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1163622
2 EX-31.1 ex31-1.htm EX-31.1 21226
3 EX-31.2 ex31-2.htm EX-31.2 21068
4 EX-32.1 ex32-1.htm EX-32.1 6464
5 EX-32.2 ex32-2.htm EX-32.2 7622
  Complete submission text file 0001641172-25-010984.txt   6943921

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE otlc-20250331.xsd EX-101.SCH 59274
7 XBRL CALCULATION FILE otlc-20250331_cal.xml EX-101.CAL 45210
8 XBRL DEFINITION FILE otlc-20250331_def.xml EX-101.DEF 283857
9 XBRL LABEL FILE otlc-20250331_lab.xml EX-101.LAB 407334
10 XBRL PRESENTATION FILE otlc-20250331_pre.xml EX-101.PRE 354480
76 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1080401
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

EIN.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 25954143
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)